Table 3.
Recommended agents for the treatment of Raynaud's∗
∗From Wigley, 2002 (1).
SR indicates sustained release; ARB, angiotensin II receptor blocker; ACE, angiotensin-converting enzyme; SSRI, selective serotonin reuptake inhibitor; PDE, phosphodiesterase; bid, twice a day; tid, three times a day.